Header Logo

Connection

THOMAS A BUCHHOLZ to Mastectomy

Back to Details
This is a "connection" page, showing publications THOMAS A BUCHHOLZ has written about Mastectomy.
THOMAS A BUCHHOLZ
Connection Strength
4.669
Mastectomy
  1. The role of postmastectomy radiotherapy in patients with stage II breast cancer. Cancer. 2018 02 01; 124(3):450-452.
    View in: PubMed
    Score: 0.390
  2. Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy. Radiat Oncol. 2013 Jan 11; 8:13.
    View in: PubMed
    Score: 0.277
  3. Optimising radiation treatment decisions for patients who receive neoadjuvant chemotherapy and mastectomy. Lancet Oncol. 2012 Jun; 13(6):e270-6.
    View in: PubMed
    Score: 0.266
  4. Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival. Breast Cancer Res Treat. 2010 Sep; 123(2):597-605.
    View in: PubMed
    Score: 0.228
  5. Effect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy. Int J Radiat Oncol Biol Phys. 2007 Dec 01; 69(5):1478-83.
    View in: PubMed
    Score: 0.191
  6. Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score. Int J Radiat Oncol Biol Phys. 2006 Oct 01; 66(2):352-7.
    View in: PubMed
    Score: 0.177
  7. The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys. 2006 Sep 01; 66(1):76-82.
    View in: PubMed
    Score: 0.175
  8. Immediate breast reconstruction can impact postmastectomy irradiation. Am J Clin Oncol. 2005 Oct; 28(5):485-94.
    View in: PubMed
    Score: 0.167
  9. Postmastectomy radiation as a component of the multidisciplinary management of breast cancer patients. Cancer J. 2005 May-Jun; 11(3):198-200.
    View in: PubMed
    Score: 0.163
  10. Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation. J Clin Oncol. 2002 Jan 01; 20(1):17-23.
    View in: PubMed
    Score: 0.129
  11. Reply to: Mastectomy skin flap thickness. Eur J Surg Oncol. 2018 07; 44(7):1119-1120.
    View in: PubMed
    Score: 0.100
  12. Multidisciplinary international survey of post-operative radiation therapy practices after nipple-sparing or skin-sparing mastectomy. Eur J Surg Oncol. 2017 Nov; 43(11):2036-2043.
    View in: PubMed
    Score: 0.096
  13. Outcomes of Post Mastectomy Radiation Therapy in Patients Receiving Axillary Lymph Node Dissection After Positive Sentinel Lymph Node Biopsy. Int J Radiat Oncol Biol Phys. 2016 11 01; 96(3):637-44.
    View in: PubMed
    Score: 0.088
  14. Complications After Mastectomy and Immediate Breast Reconstruction for Breast Cancer: A Claims-Based Analysis. Ann Surg. 2016 Feb; 263(2):219-27.
    View in: PubMed
    Score: 0.086
  15. Patterns of Local-Regional Management Following Neoadjuvant Chemotherapy in Breast Cancer: Results From ACOSOG Z1071 (Alliance). Int J Radiat Oncol Biol Phys. 2016 Mar 01; 94(3):493-502.
    View in: PubMed
    Score: 0.084
  16. Utilization and Outcomes of Breast Brachytherapy in Younger Women. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):91-101.
    View in: PubMed
    Score: 0.081
  17. Influence of neoadjuvant chemotherapy on radiotherapy for breast cancer. Ann Surg Oncol. 2015 May; 22(5):1434-40.
    View in: PubMed
    Score: 0.080
  18. Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiation. Stem Cells Transl Med. 2014 Jul; 3(7):849-56.
    View in: PubMed
    Score: 0.076
  19. Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment. Int J Radiat Oncol Biol Phys. 2014 Jun 01; 89(2):392-8.
    View in: PubMed
    Score: 0.075
  20. Benefit of adjuvant brachytherapy versus external beam radiation for early breast cancer: impact of patient stratification on breast preservation. Int J Radiat Oncol Biol Phys. 2014 Feb 01; 88(2):274-84.
    View in: PubMed
    Score: 0.074
  21. Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy. Breast Cancer Res. 2012 May 23; 14(3):R82.
    View in: PubMed
    Score: 0.066
  22. Association between treatment with brachytherapy vs whole-breast irradiation and subsequent mastectomy, complications, and survival among older women with invasive breast cancer. JAMA. 2012 May 02; 307(17):1827-37.
    View in: PubMed
    Score: 0.066
  23. Pretreatment staging positron emission tomography/computed tomography in patients with inflammatory breast cancer influences radiation treatment field designs. Int J Radiat Oncol Biol Phys. 2012 Aug 01; 83(5):1381-6.
    View in: PubMed
    Score: 0.065
  24. Impact of evidence-based clinical guidelines on the adoption of postmastectomy radiation in older women. Cancer. 2011 Oct 15; 117(20):4595-605.
    View in: PubMed
    Score: 0.062
  25. A multidisciplinary protocol for planned skin-preserving delayed breast reconstruction for patients with locally advanced breast cancer requiring postmastectomy radiation therapy: 3-year follow-up. Plast Reconstr Surg. 2011 Jun; 127(6):2154-2166.
    View in: PubMed
    Score: 0.062
  26. The impact of age on outcome in early-stage breast cancer. Semin Radiat Oncol. 2011 Jan; 21(1):26-34.
    View in: PubMed
    Score: 0.060
  27. Long-term outcomes in patients with isolated supraclavicular nodal recurrence after mastectomy and doxorubicin-based chemotherapy for breast cancer. Int J Radiat Oncol Biol Phys. 2011 Aug 01; 80(5):1453-7.
    View in: PubMed
    Score: 0.060
  28. Population-based analysis of occult primary breast cancer with axillary lymph node metastasis. Cancer. 2010 Sep 01; 116(17):4000-6.
    View in: PubMed
    Score: 0.059
  29. Even low-level HER2 expression may be associated with worse outcome in node-positive breast cancer. Am J Surg Pathol. 2009 May; 33(5):759-67.
    View in: PubMed
    Score: 0.054
  30. Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach. Int J Radiat Oncol Biol Phys. 2009 Mar 01; 73(3):734-44.
    View in: PubMed
    Score: 0.051
  31. Locoregional treatment outcomes after multimodality management of inflammatory breast cancer. Int J Radiat Oncol Biol Phys. 2008 Oct 01; 72(2):474-84.
    View in: PubMed
    Score: 0.050
  32. Risk of hypothyroidism in older breast cancer patients treated with radiation. Cancer. 2008 Mar 15; 112(6):1371-9.
    View in: PubMed
    Score: 0.050
  33. Controversies over the role of radiation therapy for ductal carcinoma in situ. Expert Rev Anticancer Ther. 2008 Mar; 8(3):433-41.
    View in: PubMed
    Score: 0.049
  34. Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1004-9.
    View in: PubMed
    Score: 0.046
  35. African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapy. Cancer. 2006 Dec 01; 107(11):2662-8.
    View in: PubMed
    Score: 0.045
  36. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Jun 01; 62(2):351-7.
    View in: PubMed
    Score: 0.041
  37. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J Clin Oncol. 2004 Dec 01; 22(23):4691-9.
    View in: PubMed
    Score: 0.039
  38. In regard to post mastectomy radiotherapy. Int J Radiat Oncol Biol Phys. 2004 Oct 01; 60(2):686-7; author reply 687-8.
    View in: PubMed
    Score: 0.039
  39. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys. 2004 May 01; 59(1):138-45.
    View in: PubMed
    Score: 0.038
  40. Delayed-immediate breast reconstruction. Plast Reconstr Surg. 2004 May; 113(6):1617-28.
    View in: PubMed
    Score: 0.038
  41. Treatment and outcome of patients with chest wall recurrence after mastectomy and breast reconstruction. Am J Surg. 2004 Feb; 187(2):164-9.
    View in: PubMed
    Score: 0.037
  42. Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation. Int J Radiat Oncol Biol Phys. 2003 Oct 01; 57(2):336-44.
    View in: PubMed
    Score: 0.036
  43. Outcome of treatment for breast cancer patients with chest wall recurrence according to initial stage: implications for post-mastectomy radiation therapy. Int J Radiat Oncol Biol Phys. 2003 Sep 01; 57(1):128-35.
    View in: PubMed
    Score: 0.036
  44. Chest wall recurrence after mastectomy does not always portend a dismal outcome. Ann Surg Oncol. 2003 Jul; 10(6):628-34.
    View in: PubMed
    Score: 0.036
  45. Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy. Int J Radiat Oncol Biol Phys. 2002 Jul 15; 53(4):880-8.
    View in: PubMed
    Score: 0.033
  46. Controversies regarding the use of radiation after mastectomy in breast cancer. Oncologist. 2002; 7(6):539-46.
    View in: PubMed
    Score: 0.032
  47. A custom three-dimensional electron bolus technique for optimization of postmastectomy irradiation. Int J Radiat Oncol Biol Phys. 2001 Nov 15; 51(4):1142-51.
    View in: PubMed
    Score: 0.032
  48. Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases. Ann Surg Oncol. 2001 Jun; 8(5):425-31.
    View in: PubMed
    Score: 0.031
  49. Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer. JAMA Oncol. 2020 04 01; 6(4):505-511.
    View in: PubMed
    Score: 0.029
  50. Importance of radiation therapy for breast cancer patients treated with high-dose chemotherapy and stem cell transplant. Int J Radiat Oncol Biol Phys. 2000 Jan 15; 46(2):337-43.
    View in: PubMed
    Score: 0.028
  51. Impact of Radiation on Locoregional Control in Women with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Lymph Node Dissection: Results from ACOSOG Z1071 Clinical Trial. Int J Radiat Oncol Biol Phys. 2019 09 01; 105(1):174-182.
    View in: PubMed
    Score: 0.027
  52. Postmastectomy Radiation Treatment Rates as a Quality Measure: An Opportunity for Compliance Through Collaboration. Ann Surg Oncol. 2016 08; 23(8):2377-9.
    View in: PubMed
    Score: 0.022
  53. Trends in Local Therapy Utilization and Cost for Early-Stage Breast Cancer in Older Women: Implications for Payment and Policy Reform. Int J Radiat Oncol Biol Phys. 2016 06 01; 95(2):605-16.
    View in: PubMed
    Score: 0.021
  54. Outcomes After Multidisciplinary Treatment of Inflammatory Breast Cancer in the Era of Neoadjuvant HER2-directed Therapy. Am J Clin Oncol. 2015 Jun; 38(3):242-7.
    View in: PubMed
    Score: 0.020
  55. Metastatic Tumor Volume and Extranodal Tumor Extension: Clinical Significance in Patients With Stage II Breast Cancer. Arch Pathol Lab Med. 2015 Oct; 139(10):1288-94.
    View in: PubMed
    Score: 0.020
  56. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013 Oct 09; 310(14):1455-61.
    View in: PubMed
    Score: 0.018
  57. Effect of delay in radiation in the combined modality treatment of breast cancer. Int J Radiat Oncol Biol Phys. 1993 Apr 30; 26(1):23-35.
    View in: PubMed
    Score: 0.018
  58. Evaluating locoregional recurrence in breast cancer. Int J Radiat Oncol Biol Phys. 2003 Mar 01; 55(3):850-1; author reply 851.
    View in: PubMed
    Score: 0.017
  59. Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer. Int J Radiat Oncol Biol Phys. 2011 Nov 01; 81(3):782-7.
    View in: PubMed
    Score: 0.016
  60. Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome. Cancer. 2011 Dec 15; 117(24):5476-84.
    View in: PubMed
    Score: 0.016
  61. Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control. Breast Cancer Res Treat. 2011 Jul; 128(2):421-7.
    View in: PubMed
    Score: 0.015
  62. Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy. Ann Surg Oncol. 2010 Nov; 17(11):2899-908.
    View in: PubMed
    Score: 0.014
  63. Use of postmastectomy radiotherapy in older women. Int J Radiat Oncol Biol Phys. 2008 May 01; 71(1):98-106.
    View in: PubMed
    Score: 0.012
  64. Low local recurrence rate without postmastectomy radiation in node-negative breast cancer patients with tumors 5 cm and larger. Int J Radiat Oncol Biol Phys. 2006 Oct 01; 66(2):358-64.
    View in: PubMed
    Score: 0.011
  65. Metaplastic sarcomatoid carcinoma of the breast with absent or minimal overt invasive carcinomatous component: a misnomer. Am J Surg Pathol. 2005 Nov; 29(11):1456-63.
    View in: PubMed
    Score: 0.011
  66. Now and later? The sticky question of lymph node management in patients receiving preoperative chemotherapy. Ann Surg Oncol. 2005 Sep; 12(9):683-5.
    View in: PubMed
    Score: 0.010
  67. Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma. Cancer. 2004 Feb 01; 100(3):499-506.
    View in: PubMed
    Score: 0.009
  68. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol. 2000 Aug; 18(15):2817-27.
    View in: PubMed
    Score: 0.007
  69. Local-regional control of recurrent breast carcinoma after mastectomy: does hyperfractionated accelerated radiotherapy improve local control? Int J Radiat Oncol Biol Phys. 1999 Apr 01; 44(1):105-12.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.